A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions
about
A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling.Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2KExpression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cellsIdentification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer.Clinical applications of mouse models for breast cancer engaging HER2/neu.Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation.
P2860
A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Tumor initiating cell-enrich ...... oversies and future directions
@en
A Tumor initiating cell-enrich ...... versies and future directions.
@nl
type
label
A Tumor initiating cell-enrich ...... oversies and future directions
@en
A Tumor initiating cell-enrich ...... versies and future directions.
@nl
prefLabel
A Tumor initiating cell-enrich ...... oversies and future directions
@en
A Tumor initiating cell-enrich ...... versies and future directions.
@nl
P2093
P2860
P356
P1433
P1476
A Tumor initiating cell-enrich ...... oversies and future directions
@en
P2093
Eldad Zacksenhaus
Jeff C Liu
Sean E Egan
P2860
P304
P356
10.18632/ONCOTARGET.1170
P407
P577
2013-08-01T00:00:00Z